(S)-N3-HABA (DCHA) is a unique azido-functionalized linker intermediate used in ADC synthesis, facilitating efficient bioconjugation and controlled payload release. It is critical for designing cleavable and stable antibody-drug conjugates. Keywords: ADC linker, azide linker, cleavable linker, bioconjugation.
Structure of
* For research and manufacturing use only. We do not sell to patients.
Size | Price | Stock | Quantity |
---|---|---|---|
-- | $-- | In stock |
Looking for different specifications? Click to request a custom quote!
Capabilities & Facilities
(S)-N3-HABA (DCHA), a chemical compound with diverse applications in bioscience and related domains, showcases versatility in its usage. Here are four key applications, each presented with a high degree of perplexity and burstiness:
Enzyme Kinetics: At the forefront of enzyme kinetics studies, (S)-N3-HABA (DCHA) emerges as a pivotal player, enabling researchers to delve into the intricate binding interactions between enzymes and substrates. Acting as a versatile substrate analog or inhibitor, it facilitates a deep exploration of enzyme specificity and mechanism of action. These profound insights play a crucial role in shaping targeted enzyme-based therapies, as well as refining industrial enzymatic processes, paving the way for enhanced efficiency and efficacy.
Protein-Ligand Interaction: Within the realm of structural biology, (S)-N3-HABA (DCHA) takes center stage as a potent tool for scrutinizing protein-ligand interactions through cutting-edge techniques such as X-ray crystallography and NMR spectroscopy. By offering detailed insights into binding sites and molecular interactions, it becomes an indispensable asset in drug design and the creation of novel therapeutic agents, laying the foundation for innovative solutions in healthcare.
Biochemical Assays: Embracing the world of biochemical assays, (S)-N3-HABA (DCHA) emerges as a valuable component for quantifying enzyme activities and screening potential inhibitors. Its unique binding properties make it a preferred choice for incorporation into colorimetric or spectrophotometric assays, fueling advancements in high-throughput screening for drug discovery and biochemical research. This application holds immense promise in accelerating the pace of scientific discovery and innovation.
Pharmaceutical Development: In the realm of pharmaceutical research, (S)-N3-HABA (DCHA) stands out as a cornerstone, serving as a reference compound or foundational material for the synthesis of groundbreaking drug candidates. With its structural properties acting as a versatile scaffold, researchers can tailor its chemical structure to optimize pharmacokinetic and pharmacodynamic properties, ultimately leading to the development of safer and more effective medications. This transformative potential positions (S)-N3-HABA (DCHA) as a catalyst for innovation in pharmaceutical sciences.
Contact our experts today for pricing and comprehensive details on our ADC offerings.
From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.
Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.
Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.